Literature DB >> 23662897

Lane-by-lane sequencing using Illumina's Genome Analyzer II.

Michael T Gravina1, Jenny H Lin, Stuart S Levine.   

Abstract

Next-generation sequencing has become an essential tool in molecular biology that has been successfully applied to a broad variety of experimental approaches. While several platforms for next-generation sequencing exist, the most commonly used approach is sequencing-by-synthesis, implemented on Illumina's Genome Analyzer II (GAII) and HiSeq2000 systems. A key constraint of these sequencers is the need to run multiple lanes of samples with identical parameters as part of a single flowcell. Here, we present a series of modifications to the Illumina Genome Analyzer II, along with a script generating tool, that allow users to run the GAII in a lane-by-lane manner. Any number of lanes can be run at one time. Repeated use of the same flowcell on multiple sequencing runs does not appreciably reduce the intensity, cluster density, or accuracy of the run. These modifications will enable smaller-scale experiments with unusual design parameters to be run routinely on the GAII.

Entities:  

Mesh:

Year:  2013        PMID: 23662897      PMCID: PMC4345167          DOI: 10.2144/000114032

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  7 in total

Review 1.  Next-generation sequencing technologies for environmental DNA research.

Authors:  Shadi Shokralla; Jennifer L Spall; Joel F Gibson; Mehrdad Hajibabaei
Journal:  Mol Ecol       Date:  2012-04       Impact factor: 6.185

Review 2.  The discovery of human genetic variations and their use as disease markers: past, present and future.

Authors:  Chee Seng Ku; En Yun Loy; Agus Salim; Yudi Pawitan; Kee Seng Chia
Journal:  J Hum Genet       Date:  2010-05-20       Impact factor: 3.172

Review 3.  RNA sequencing: advances, challenges and opportunities.

Authors:  Fatih Ozsolak; Patrice M Milos
Journal:  Nat Rev Genet       Date:  2010-12-30       Impact factor: 53.242

4.  Genome sequencing in microfabricated high-density picolitre reactors.

Authors:  Marcel Margulies; Michael Egholm; William E Altman; Said Attiya; Joel S Bader; Lisa A Bemben; Jan Berka; Michael S Braverman; Yi-Ju Chen; Zhoutao Chen; Scott B Dewell; Lei Du; Joseph M Fierro; Xavier V Gomes; Brian C Godwin; Wen He; Scott Helgesen; Chun Heen Ho; Chun He Ho; Gerard P Irzyk; Szilveszter C Jando; Maria L I Alenquer; Thomas P Jarvie; Kshama B Jirage; Jong-Bum Kim; James R Knight; Janna R Lanza; John H Leamon; Steven M Lefkowitz; Ming Lei; Jing Li; Kenton L Lohman; Hong Lu; Vinod B Makhijani; Keith E McDade; Michael P McKenna; Eugene W Myers; Elizabeth Nickerson; John R Nobile; Ramona Plant; Bernard P Puc; Michael T Ronan; George T Roth; Gary J Sarkis; Jan Fredrik Simons; John W Simpson; Maithreyan Srinivasan; Karrie R Tartaro; Alexander Tomasz; Kari A Vogt; Greg A Volkmer; Shally H Wang; Yong Wang; Michael P Weiner; Pengguang Yu; Richard F Begley; Jonathan M Rothberg
Journal:  Nature       Date:  2005-07-31       Impact factor: 49.962

5.  Direct measurement of DNA affinity landscapes on a high-throughput sequencing instrument.

Authors:  Razvan Nutiu; Robin C Friedman; Shujun Luo; Irina Khrebtukova; David Silva; Robin Li; Lu Zhang; Gary P Schroth; Christopher B Burge
Journal:  Nat Biotechnol       Date:  2011-06-26       Impact factor: 54.908

Review 6.  Genotype and SNP calling from next-generation sequencing data.

Authors:  Rasmus Nielsen; Joshua S Paul; Anders Albrechtsen; Yun S Song
Journal:  Nat Rev Genet       Date:  2011-06       Impact factor: 53.242

Review 7.  ChIP-seq and beyond: new and improved methodologies to detect and characterize protein-DNA interactions.

Authors:  Terrence S Furey
Journal:  Nat Rev Genet       Date:  2012-10-23       Impact factor: 53.242

  7 in total
  1 in total

1.  Quantitative assessment of RNA-protein interactions with high-throughput sequencing-RNA affinity profiling.

Authors:  Abdullah Ozer; Jacob M Tome; Robin C Friedman; Dan Gheba; Gary P Schroth; John T Lis
Journal:  Nat Protoc       Date:  2015-07-16       Impact factor: 13.491

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.